Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people aged 11–55 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback